0074-2310 : Rinvoq 30 mg Oral Tablet, Extended Release


NDC: 0074-2310
Labeler: Abbvie Inc.
Product Type: Human Prescription Drug
Drug Name:  Rinvoq
Dosage Form: Oral Tablet, Extended Release
Application #: NDA211675
Rev. Date: 


NDC Package Codes:

  • 0074-2310-20: 14 TABLET, EXTENDED RELEASE IN 1 BOTTLE (0074‑2310‑20)
  • 0074-2310-30: 30 TABLET, EXTENDED RELEASE IN 1 BOTTLE (0074‑2310‑30)

Active Ingredients:

  • Upadacitinib

Dosage Strength:

  • 30 mg

Pharmaceutical Classes:

  • Janus Kinase Inhibitor [EPC]
  • Janus Kinase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0074-1043 Rinvoq 45 mg Oral Tablet, Extended Release by Abbvie Inc.
  • 0074-2306 Rinvoq 15 mg Oral Tablet, Extended Release by Abbvie Inc.
  • 0074-2320 Rinvoq 1 mg/ml Oral Solution by Abbvie Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0074-2310 QR Code

< Prev: 0074-2306Next: 0074-2320 >

Related Discussions:

Rinvoq for rheumatoid arthritis
Hi ~ Just got the rheumatoid arthritis tap on the shoulder today. Rinvoq seems to be advertised a lot but I’d sure... 5 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.